Clinical trials
Breast Cancer With Low to Intermediate HER2 Expression clinical trials
Below are recruiting breast cancer with low to intermediate her2 expression clinical trials, each written for real people, not researchers. We’re tracking 4 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07844473Recruiting
Magtrace dye to guide surgery for early breast cancer
This trial tests using a special dye called Magtrace to help surgeons find and remove the cancer and check nearby lymph nodes during breast-conserving surgery. It might help make the surgery more precise and avoid extra procedures.
MadinahAges 18 years+ - NCT07630402Recruiting
Heart Imaging Study for Women With Early Breast Cancer
This study helps doctors find the best way to monitor heart health in women with HER2-positive breast cancer who are receiving a type of targeted chemotherapy. The goal is to catch any heart problems early and keep you safe during treatment.
Rochester, New YorkAges 18–79 - NCT07331506Recruiting
Early detection of breast cancer with a blood test
This trial tests a new blood test called Oncoliq to see if it can find breast cancer early. It compares results from people with breast cancer and people without cancer.
Buenos Aires, Buenos AiresAges 40–70 - NCT05059444Recruiting
Blood test to catch cancer early after treatment
This study looks for signs of cancer left in the body after treatment using a simple blood test (called a liquid biopsy). It aims to see if the test can catch cancer that might come back earlier than regular scans.
Birmingham, AlabamaAges 18 years+
Hear when a new Breast Cancer With Low to Intermediate HER2 Expression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for breast cancer with low to intermediate her2 expression?
- Yes. Clin2 currently lists 4 recruiting breast cancer with low to intermediate her2 expression studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a breast cancer with low to intermediate her2 expression trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a breast cancer with low to intermediate her2 expression trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.